Decibel Therapeutics, Inc. (DBTX) has 5 open-market insider trades by 5 insiders since 2021. The most active filer is Peter A. Thompson, Director & 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Peter A. Thompson | Dir10% Owner | — | 1 | $30.0M | 2021-02-17 |
| Casdin Partners Master Fund, L.P. | 10% Owner | — | 1 | $10.3M | 2021-02-17 |
| Glaxosmithkline PLC | Dir | — | 1 | $2.7M | 2021-02-17 |
| Matthew Foy | Dir10% Owner | — | 1 | $2.7M | 2021-02-17 |
| Laurence Reid | CEOPres | — | 1 | $76K | 2023-09-25 |
| Orbimed Advisors LLC | Dir10% Owner | — | 0 | — | 2021-02-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Anna Trask | — | Sell | $2K | 2022-01-03 |
| Anna Trask | — | Sell | $34K | 2021-12-02 |
| Anna Trask | — | Sell | $3K | 2021-11-03 |
| Anna Trask | SEE REMARKS | Sell | $41K | 2021-11-02 |
| Anna Trask | — | Sell | $40K | 2021-10-14 |
| Laurence Reid | CEO & President | Buy | $76K | 2021-09-15 |
Companies that share insiders with DBTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Glaxosmithkline PLC | Director | Buy | $2.7M | 2021-02-17 |
| Peter A. Thompson | Director & 10% Owner | Buy | $30.0M | 2021-02-17 |
| Casdin Partners Master Fund, L.P. | 10% Owner | Buy | $10.3M | 2021-02-17 |